Border to Coast Pensions Partnership Ltd Cuts Stock Holdings in Danaher Corporation (NYSE:DHR)

Border to Coast Pensions Partnership Ltd lessened its position in Danaher Corporation (NYSE:DHR - Free Report) by 21.7% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 155,913 shares of the conglomerate's stock after selling 43,237 shares during the quarter. Border to Coast Pensions Partnership Ltd's holdings in Danaher were worth $31,962,000 as of its most recent SEC filing.

A number of other institutional investors have also recently made changes to their positions in DHR. Artemis Investment Management LLP purchased a new stake in Danaher during the 1st quarter valued at about $13,225,000. Canvas Wealth Advisors LLC purchased a new stake in shares of Danaher in the first quarter valued at approximately $334,000. Diversified Trust Co lifted its position in Danaher by 6.9% during the first quarter. Diversified Trust Co now owns 5,861 shares of the conglomerate's stock worth $1,202,000 after buying an additional 379 shares in the last quarter. CNB Bank boosted its stake in Danaher by 11.8% during the first quarter. CNB Bank now owns 4,221 shares of the conglomerate's stock worth $865,000 after buying an additional 444 shares during the last quarter. Finally, Nadler Financial Group Inc. raised its holdings in shares of Danaher by 32.1% during the 1st quarter. Nadler Financial Group Inc. now owns 1,900 shares of the conglomerate's stock worth $390,000 after acquiring an additional 462 shares during the period. 79.05% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at Danaher

In other Danaher news, EVP Christopher Paul Riley sold 15,805 shares of Danaher stock in a transaction that occurred on Wednesday, April 30th. The shares were sold at an average price of $198.00, for a total value of $3,129,390.00. Following the completion of the sale, the executive vice president now directly owns 15,179 shares of the company's stock, valued at approximately $3,005,442. The trade was a 51.01% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Chairman Steven M. Rales sold 1,250,000 shares of the stock in a transaction on Monday, May 12th. The stock was sold at an average price of $196.74, for a total value of $245,925,000.00. Following the transaction, the chairman now directly owns 3,105,808 shares in the company, valued at approximately $611,036,665.92. This represents a 28.70% decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 11.10% of the company's stock.

Wall Street Analysts Forecast Growth

Several research firms recently issued reports on DHR. Royal Bank Of Canada reaffirmed an "outperform" rating and set a $250.00 target price on shares of Danaher in a research note on Wednesday, April 23rd. UBS Group reduced their price objective on shares of Danaher from $275.00 to $240.00 and set a "buy" rating on the stock in a report on Wednesday, April 23rd. TD Cowen increased their target price on shares of Danaher from $240.00 to $248.00 and gave the stock a "buy" rating in a research note on Wednesday, April 23rd. The Goldman Sachs Group dropped their target price on shares of Danaher from $260.00 to $240.00 and set a "neutral" rating for the company in a report on Wednesday, April 23rd. Finally, HSBC decreased their price target on Danaher from $270.00 to $240.00 in a research note on Friday, April 25th. Five analysts have rated the stock with a hold rating and sixteen have given a buy rating to the stock. According to MarketBeat, Danaher currently has an average rating of "Moderate Buy" and a consensus price target of $248.61.

Danaher Stock Up 0.4%

DHR stock opened at $201.88 on Friday. The stock has a market capitalization of $144.48 billion, a PE ratio of 39.20, a price-to-earnings-growth ratio of 2.82 and a beta of 0.77. Danaher Corporation has a one year low of $171.00 and a one year high of $281.70. The company has a fifty day moving average of $194.61 and a 200-day moving average of $208.77. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.05 and a current ratio of 1.43.

Danaher (NYSE:DHR - Get Free Report) last posted its quarterly earnings results on Tuesday, April 22nd. The conglomerate reported $1.88 EPS for the quarter, beating the consensus estimate of $1.62 by $0.26. Danaher had a return on equity of 10.80% and a net margin of 15.81%. The business had revenue of $5.74 billion during the quarter, compared to analysts' expectations of $5.58 billion. As a group, analysts expect that Danaher Corporation will post 7.63 EPS for the current year.

Danaher Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, July 25th. Stockholders of record on Friday, June 27th will be paid a dividend of $0.32 per share. This represents a $1.28 annualized dividend and a dividend yield of 0.63%. Danaher's dividend payout ratio (DPR) is 24.85%.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.